OneMedNet CFO sells 8,500 shares to cover taxes

The sale footnote attributes the common-stock sales to tax obligations arising when restricted stock units vested and settled.

Rhea-AI Filing Summary

OneMedNet Corp (ONMD) Chief Financial Officer and director Robert Lawrence Golden reported direct grants of 35,000 restricted stock units on July 6, 2026, and 10,000 restricted stock units on January 1, 2026. The January award amount reflects the 1-for-10 reverse stock split on September 29, 2026. The July grant vests in installments subject to continued service; the January grant vests in full on December 31, 2026, subject to the Consulting Agreement terms.

Golden also reported direct sales of 8,500 common shares to cover tax obligations upon RSU vesting and settlement: 2,500 shares at $6.6000 per share on September 14, 3,000 at $6.3000 on September 15, and 3,000 at $6.6300 on September 21, 2026. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Net Seller: 8,500 shares

Net Sell 5 txns

Insider Golden Robert Lawrence

Role Chief Financial Officer

Sold 8,500 shs ($55K)

Type	Security	Shares	Price	Value
Sale	Common Stock F5	3,000	$6.63	$20K
Sale	Common Stock F5	3,000	$6.30	$19K
Sale	Common Stock F5	2,500	$6.60	$17K
Grant/Award	Common Stock F2, F3	35,000	$0.00	$0.00
Grant/Award	Common Stock F1, F3, F4	10,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 91,291 shares (Direct)

Footnotes (5)

1. F1. Represents restricted stock units ("RSUs") granted pursuant to contractor arrangements with the reporting person. The RSUs vest in full on December 31, 2026, subject to the terms of Section 7.2.2 of the Consulting Agreement, dated January 1, 2026, between the issuer and Mr. Golden.
2. F2. Represents RSUs granted pursuant to contractor arrangements with the reporting person. The RSUs vest with respect to 1/3 of the shares on the first anniversary of the vesting start date of January 1, 2026, with the remaining RSUs vesting in equal quarterly installments on the last day of each fiscal quarter over 24 months thereafter, subject to the reporting person's continued service with the issuer through each vesting date.
3. F3. Each RSU represents the contingent right to receive one share of the issuer's common stock.
4. F4. All share amounts and share prices shown in this report have been adjusted to reflect the 1-for-10 reverse stock split by the issuer on September 29, 2026.
5. F5. Represents shares sold by the reporting person to cover tax obligations upon the vesting and settlement of RSUs.

Key Figures

Common shares sold: 2,500 shares at $6.6000 per share Common shares sold: 3,000 shares at $6.3000 per share Common shares sold: 3,000 shares at $6.6300 per share +2 more

5 metrics

Common shares sold 2,500 shares at $6.6000 per share September 14, 2026; sold to cover tax obligations upon RSU vesting and settlement

Common shares sold 3,000 shares at $6.3000 per share September 15, 2026; sold to cover tax obligations upon RSU vesting and settlement

Common shares sold 3,000 shares at $6.6300 per share September 21, 2026; sold to cover tax obligations upon RSU vesting and settlement

RSUs granted 35,000 RSUs July 6, 2026

RSUs granted 10,000 RSUs January 1, 2026; amount adjusted to reflect the 1-for-10 reverse stock split on September 29, 2026

Key Terms

restricted stock units, vesting start date, contingent right, reverse stock split

4 terms

restricted stock units financial

"RSUs granted pursuant to contractor arrangements"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vesting start date financial

"first anniversary of the vesting start date of January 1, 2026"

contingent right financial

"Each RSU represents the contingent right to receive one share"

reverse stock split financial

"1-for-10 reverse stock split by the issuer on September 29, 2026"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ONMD shares did CFO Robert Lawrence Golden sell, and at what prices?

Robert Lawrence Golden sold 8,500 shares in three reported transactions: 2,500 shares at $6.6000 per share on September 14, 3,000 at $6.3000 on September 15, and 3,000 at $6.6300 on September 21, 2026. The sales covered tax obligations upon RSU vesting and settlement; no Rule 10b5-1 plan is reported.

What RSU awards did OneMedNet Corp's CFO report?

Golden reported grants of 35,000 RSUs on July 6, 2026, and 10,000 RSUs on January 1, 2026. The January award amount reflects the 1-for-10 reverse stock split on September 29, 2026. Each RSU represents a contingent right to receive one common share.

When do Robert Lawrence Golden's ONMD RSUs vest?

The 35,000 RSUs granted July 6, 2026 vest one-third on the first anniversary of the January 1, 2026 vesting start date, with the remaining RSUs vesting in equal quarterly installments on the last day of each fiscal quarter over the following 24 months, subject to continued service through each vesting date. The 10,000 RSUs granted January 1 vest in full on December 31, 2026, subject to the Consulting Agreement terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/09/2026 - 09:30 PM Accepted by SEC EDGAR 10/09/2026 - 09:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Golden Robert Lawrence

(Last) (First) (Middle)

6385 OLD SHADY OAK ROAD, SUITE 250

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
OneMedNet Corp [ ONMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
01/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/01/2026		A		10,000(1)(3)	A	$0.00	64,791(4)	D
Common Stock	07/06/2026		A		35,000(2)(3)	A	$0.00	99,791	D
Common Stock	09/14/2026		S(5)		2,500	D	$6.6	97,291	D
Common Stock	09/15/2026		S(5)		3,000	D	$6.3	94,291	D
Common Stock	09/21/2026		S(5)		3,000	D	$6.63	91,291	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted pursuant to contractor arrangements with the reporting person. The RSUs vest in full on December 31, 2026, subject to the terms of Section 7.2.2 of the Consulting Agreement, dated January 1, 2026, between the issuer and Mr. Golden.

2. Represents RSUs granted pursuant to contractor arrangements with the reporting person. The RSUs vest with respect to 1/3 of the shares on the first anniversary of the vesting start date of January 1, 2026, with the remaining RSUs vesting in equal quarterly installments on the last day of each fiscal quarter over 24 months thereafter, subject to the reporting person's continued service with the issuer through each vesting date.

3. Each RSU represents the contingent right to receive one share of the issuer's common stock.

4. All share amounts and share prices shown in this report have been adjusted to reflect the 1-for-10 reverse stock split by the issuer on September 29, 2026.

5. Represents shares sold by the reporting person to cover tax obligations upon the vesting and settlement of RSUs.

	/s/ Robert Golden	10/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)